Sinking Success Rates of Treatment of Heroin Addicts: Are We Missing the Boat?

References

• Armenian S H, Chutuape M A, Stitzer M L. Predictors of discharges against medical advice from a short-term hospital detoxification unit. Drug and Alcohol Dependency 1999; 567(1)1–8
   Google Scholar
• Boweresox J A. Buprenorphine may soon be heroin treatment option. NIDA NOTES 1995; 10(1), http://www.nida.nih.gov
   Google Scholar
• Chadderfun A. Clinical issues in using buprenorphine in the treatment of opiate dependence. Drug and Alcohol Review 2000; 19(3)329–335
   Web of Science ®Google Scholar
• Cherubin C E, Sapira J D. The medical complications of drug addiction and the medical assessment of the intravenous drug user: 25 years later. Annals of Internal Medicine 1993; 199(10)1017–1028
   Google Scholar
• Cheskin L J, Fudala P J, Johnson R E. A controlled comparison of buprenorphine and clonidine for acute detoxification from opioids. Drug and Alcohol Dependency 1994; 36: 115–121
   PubMed Web of Science ®Google Scholar
• Connor P G, Carroll K M, Shi J M, Schottenfeld R S, Kosten T R, Rounsaville B J. Three methods of opioid detoxification in a primary care setting: a randomized trial. Annals of Internal Medicine 1997; 127: 526–530
   PubMed Web of Science ®Google Scholar
• Critis-Cristoph P, Siqueland L. Psychosocial treatment of drug abuse; selected review and recommendations for national health care. Archives of General Psychiatry 1996; 53(8)749–756
   PubMed Web of Science ®Google Scholar
• Drug Abuse Warning Network (DAWN). Emergency Department Data from Drug Abuse and Warning Network. Substance Abuse and Mental Health Services Administration, Office of Applied Statistics. 1999, http://www.Samsha.gov
   Google Scholar
• Epstein J F, Gfroerer J C. Heroin abuse in the United States. Office of Applied Studies. Substance Abuse and Mental Health Services Administration, Rockville, MD, http://www.health.org/govpubs/Rpo919
   Google Scholar
• Gorski T T, Miller M. Staying Sober: A Guide for Relapse Prevention. Herald House/Independence Press, Independence, MO 1986; 157–170
   Google Scholar
• Gossip M. Clonidine and the treatment of the opiate withdrawal syndrome. Drug and Alcohol Dependency 1998; 21: 253–259
   Google Scholar
• Henney J E. Clarification on buprenorphine. Journal of the American Medical Association 2000; 284(17)143–187
   Web of Science ®Google Scholar
• Hicks M. The alternative therapy. Nursing Standard, 14(45)18
   PubMedGoogle Scholar
• Hubbard R L, Marsden M E, Harwood H J, Cavanaugh E R, Ginzburg H M. Drug Abuse Treatment: A National Study of Effectiveness. University of North Carolina Press, Chapel Hill 1994
   Google Scholar
• Joe G W, Simpson D D, Sells S B. Treatment process and relapse to opioid use during methadone maintenance. American Journal of Drug and Alcohol Abuse 1994; 20: 173–197
   PubMed Web of Science ®Google Scholar
• Leshner A I. Applying scientific research can counter rise in heroin use. NIDA Notes 1997; 12: 6, http://www.nida.nih.gov/NIDA-Notes/NNVo112N6/DirRepVo112N6.html
   Google Scholar
• Leshner A I. Science-based views of drug addictions and its treatment. 1999. The Journal of the American Medical Association 1999; 282(14)1314–1316
   PubMed Web of Science ®Google Scholar
• Leshner A I. The disease of addiction. Lippincott, Williams and Wilkins. Lippincott's Primary Care Practice. Addictions 2000; 4(3)249–253
   PubMedGoogle Scholar
• Maddux J F, Desmond D P. Ten-year follow-up after admission to methadone maintenance. American Journal of Alcohol and Drug Abuse 1992; 18(3)289–303
   PubMed Web of Science ®Google Scholar
• McGonagle D. Methadone anonymous: a 12-step program. Journal of Psychosocial Nursing and Mental Health Services 1994; 32: 5–12
   PubMedGoogle Scholar
• National Clearinghouse for Alcohol and Drug Information (NCADI). National Control Strategy: Drug Availability, http://www.health.org/govpubs/ncds98/table-20.html
   Google Scholar
• National Institutes of Health (NIH). Consensus Development Conference Statement. Effective medical treatment of opiate addiction. JAMA: The Journal of the American Medical Association 1999; 280(22)1936–1943
   Google Scholar
• National Institute on Drug Abuse (NIDA). Research Report Series. Heroin abuse and addiction. 1999, 1999 http://www.nida.nih.gov/ResearchReports/Heroin/heroin2.html
   Google Scholar
• National Institute on Drug Abuse (NIDA). 1998 National Institute of Drug Abuse Household Survey. Office of Applied Statistics, Rockville, Md 1998, http://www.Samhsa.gov/hhsurvey/hhsurvey.html
   Google Scholar
• National Institute on Drug Abuse (NIDA). 1999 National Institute of Drug Abuse Household Survey. Office of Applied Statistics, Rockville, Md. 1999, http://www.Samhsa.gov/hhsurvey/
   Google Scholar
• O'Connor P G, Fiellin D A. Pharmacologic treatment of heroin dependent patients. Annals of Internal Medicine 2000; 133(1)40–54
   PubMed Web of Science ®Google Scholar
• Opioid-related disorders: treatment principles and alternatives. Clinical Resources: Practice Guidelines of the American Psychiatric Association. APA. 1995, http://www.psych.org/clin
   Google Scholar
• O'Connor P G, Fiellin D A. Pharmacologic treatment of heroin dependent patients. Annals of Internal Medicine 2000; 133(1)40–54
   PubMed Web of Science ®Google Scholar
• O'Connor P G, Carroll K M, Shi J M. Three methods of opioid detoxification in a primary care setting, a randomized trial. Annals of Internal Medicine 1997; 127(7)526–530
   PubMed Web of Science ®Google Scholar
• Peele. Diseasing of America: Addiction Treatment Out of Control. Lexington Books, Lexington, MA 1989
   Google Scholar
• Rawson R A, Hasson A L, Huber A M, McCann M J, Ling W. A 3-year progress report on the implementation of LAAM in the United States. Addiction 1998; 93: 533–540
   PubMed Web of Science ®Google Scholar
• Sajo E. Pharmacology of substance abuse. Lippincott, Williams and Wilkins. Lippincott's Primary Care Practice 2000; 4(3)319–335
   PubMedGoogle Scholar
• Sees K L, Delucchi K L, Masson C, Rosen A, Clark H, Westley H, Robillard H, Banys P, Hall S M. Methadone Maintenance for opioid dependence. The Journal of the American Medical Association 2000; 284(6)694–695
   Google Scholar
• Shufman E N, Porat S, Witztum E, Gandacu D, Bar-Hamburger R, Ginath Y. The efficacy of naltrexone in preventing reabuse of heroin after detoxification. Biological Psychiatry 1994; 35(12)935–945
   PubMed Web of Science ®Google Scholar
• Ward J, Hall W, Mattick R P. Role of maintenance treatment in opioid dependence. Lancet 1999; 353: 221–226
   PubMed Web of Science ®Google Scholar
• White B K, Bouton L L, Garris S K, Humphreys P T, Miltier J. The role of the nurse case manager in substance abuse treatment. Journal of Addictions Nursing 1998; 10: 3
   Google Scholar